493 related articles for article (PubMed ID: 9628899)
1. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin.
Simcha I; Shtutman M; Salomon D; Zhurinsky J; Sadot E; Geiger B; Ben-Ze'ev A
J Cell Biol; 1998 Jun; 141(6):1433-48. PubMed ID: 9628899
[TBL] [Abstract][Full Text] [Related]
2. The dual role of cytoskeletal anchor proteins in cell adhesion and signal transduction.
Ben-Ze'ev A
Ann N Y Acad Sci; 1999; 886():37-47. PubMed ID: 10667201
[TBL] [Abstract][Full Text] [Related]
3. Differential mechanisms of LEF/TCF family-dependent transcriptional activation by beta-catenin and plakoglobin.
Zhurinsky J; Shtutman M; Ben-Ze'ev A
Mol Cell Biol; 2000 Jun; 20(12):4238-52. PubMed ID: 10825188
[TBL] [Abstract][Full Text] [Related]
4. Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system.
Sadot E; Simcha I; Iwai K; Ciechanover A; Geiger B; Ben-Ze'ev A
Oncogene; 2000 Apr; 19(16):1992-2001. PubMed ID: 10803460
[TBL] [Abstract][Full Text] [Related]
5. Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system.
Salomon D; Sacco PA; Roy SG; Simcha I; Johnson KR; Wheelock MJ; Ben-Ze'ev A
J Cell Biol; 1997 Dec; 139(5):1325-35. PubMed ID: 9382877
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte adherens junctions initiate nuclear signaling by translocation of plakoglobin from the membrane to the nucleus.
Hu P; Berkowitz P; O'Keefe EJ; Rubenstein DS
J Invest Dermatol; 2003 Aug; 121(2):242-51. PubMed ID: 12880414
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators.
Kim K; Pang KM; Evans M; Hay ED
Mol Biol Cell; 2000 Oct; 11(10):3509-23. PubMed ID: 11029052
[TBL] [Abstract][Full Text] [Related]
8. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.
Maeda O; Usami N; Kondo M; Takahashi M; Goto H; Shimokata K; Kusugami K; Sekido Y
Oncogene; 2004 Jan; 23(4):964-72. PubMed ID: 14661054
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of beta-catenin-mediated transactivation by cadherin derivatives.
Sadot E; Simcha I; Shtutman M; Ben-Ze'ev A; Geiger B
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15339-44. PubMed ID: 9860970
[TBL] [Abstract][Full Text] [Related]
10. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.
Conacci-Sorrell ME; Ben-Yedidia T; Shtutman M; Feinstein E; Einat P; Ben-Ze'ev A
Genes Dev; 2002 Aug; 16(16):2058-72. PubMed ID: 12183361
[TBL] [Abstract][Full Text] [Related]
11. A comparative evaluation of beta-catenin and plakoglobin signaling activity.
Williams BO; Barish GD; Klymkowsky MW; Varmus HE
Oncogene; 2000 Nov; 19(50):5720-8. PubMed ID: 11126358
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation.
Orsulic S; Huber O; Aberle H; Arnold S; Kemler R
J Cell Sci; 1999 Apr; 112 ( Pt 8)():1237-45. PubMed ID: 10085258
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of multiple transactivating elements in beta-catenin, some of which interact with the TATA-binding protein in vitro.
Hecht A; Litterst CM; Huber O; Kemler R
J Biol Chem; 1999 Jun; 274(25):18017-25. PubMed ID: 10364252
[TBL] [Abstract][Full Text] [Related]
14. PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription.
Shtutman M; Zhurinsky J; Oren M; Levina E; Ben-Ze'ev A
Cancer Res; 2002 Oct; 62(20):5947-54. PubMed ID: 12384561
[TBL] [Abstract][Full Text] [Related]
15. Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells.
Sadot E; Conacci-Sorrell M; Zhurinsky J; Shnizer D; Lando Z; Zharhary D; Kam Z; Ben-Ze'ev A; Geiger B
J Cell Sci; 2002 Jul; 115(Pt 13):2771-80. PubMed ID: 12077367
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization and formation of beta-catenin-lymphoid enhancer factor 1 complexes are not sufficient for activation of gene expression.
Prieve MG; Waterman ML
Mol Cell Biol; 1999 Jun; 19(6):4503-15. PubMed ID: 10330189
[TBL] [Abstract][Full Text] [Related]
17. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
[TBL] [Abstract][Full Text] [Related]
18. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1.
Henderson BR; Galea M; Schuechner S; Leung L
J Biol Chem; 2002 Jul; 277(27):24258-64. PubMed ID: 11986304
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function.
Kim K; Lee KY
Cell Biol Int; 2001; 25(5):421-7. PubMed ID: 11401329
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.
Easwaran V; Song V; Polakis P; Byers S
J Biol Chem; 1999 Jun; 274(23):16641-5. PubMed ID: 10347231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]